eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2012
vol. 16
 
Share:
Share:
abstract:
Original paper

Cytostatic and cytotoxic effects of tyrphostin AG1296 on RMS cells

Małgorzata Lasota
,
Andrzej Klein
,
Walentyna Balwierz

Wspolczesna Onkol 2012; 16 (1): 1–5
Online publish date: 2012/02/29
View full text Get citation
 
PlumX metrics:
Aim of the study: The aim of the work was to determine the influence of tyrphostin AG1296, an inhibitor of platelet-derived growth factor receptor (PDGFR) tyrosine kinase, on autocrine growth of rhabdomyosarcoma (RMS) cells.

Materials and methods: RMS cells were cultured in serum-free DMEM/F12 medium. Modified crystal violet (CV) and MTT methods were used to determine the RMS cells’ proliferation and viability. In­fluence of the investigated inhibitor on cell apoptosis or necrosis was determined by differential staining with Hoechst No. 33258 and propidium iodide.

Results: The AG1296 inhibitor affects RMS cell proliferation in a dose-dependent way at the concentration range 1–100 µM. At concentrations above 25 M there was 100% inhibition of growth of these cells and a cytotoxic effect was noticed. 50% inhibition of RMS cells proliferation (IC50) was observed at concentration 6.65 ±0.44 µM (determined by CV method) and 7.30 ±0.26 µM (determined by MTT method). The differential staining method shows that this inhibitor causes a cytotoxic effect.

Conclusion: The results of these experiments indicate that autocrine growth of RMS cells is regulated by at least one autocrine loop, involving platelet-derived growth factor (PDGF) and its receptor (PDGFR).

The fact that tyrphostin AG1296 is able to complete inhibition of RMS cell growth in vitro gives a chance for providing a new group of antitumor drugs, which may be more effective than the medicines used so far.
keywords:

tyrosine kinase, signal transduction, platelet-derived growth factor receptor, tyrphostin AG1296, RMS cells

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.